|
|
#1
02-25-2016, 03:22 PM
|
|||
|
|||
AstraZeneca?s $4 billion Acerta deal endorsed by orphan drug status
AstraZeneca?s $4 billion Acerta deal endorsed by orphan drug status
LONDON (Reuters) - AstraZeneca's bold move to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion in December has been vindicated, at least in part, by the award of special "orphan" status to the key experimental drug involved.  ??????? ??????: AstraZeneca?s $4 billion Acerta deal endorsed by orphan drug status || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري